We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Processing Speed as a Core Endophenotype: New Evidence from a 115-Study Meta-Analysis in Schizophrenia

MedXY Editorial Team•Dec 23, 2025•news
meta-analysisNeurocognitionschizophrenia

Highlights

  • A massive meta-analysis of 115 studies involving 10,114 individuals with schizophrenia confirms a profound impairment in processing speed, with a Hedges g effect size of -1.52.
  • While symbol coding tests are among the most sensitive markers, the impairment is not uniquely isolated, as 15 other cognitive tests showed comparable levels of deficit.
  • Key moderators of processing speed performance include age, IQ, sex, inpatient status, and specific diagnostic subtypes (schizoaffective and schizophreniform).
  • Findings suggest that processing speed deficits are a central hub for global cognitive impairment, likely rooted in disrupted brain connectivity.

Introduction: The Cognitive Core of Schizophrenia

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Intracoronary Imaging-Guided PCI: Updated Meta-Analysis Validates Cardiovascular Outcome BenefitsThis updated meta-analysis of 28 RCTs reveals significant reductions in cardiovascular events and mortality with intracoronary imaging-guided PCI versus angiography-guided PCI, highlighting the importance of lesion and geographic factors inSep 19, 2026Relapse Trajectories and Antipsychotic Discontinuation in Schizophrenia: Insights from a Meta-Analysis and Contemporary EvidenceThis review synthesizes a meta-analysis of relapse trajectories following paliperidone discontinuation with evidence on antipsychotic maintenance and discontinuation strategies, highlighting individualized risk stratification and clinical iAug 27, 2026Time-Dependent Symptom Improvement in Schizophrenia: Insights from Six Antipsychotic TrialsThis analysis of six antipsychotic trials reveals distinct temporal patterns in the improvement of schizophrenia symptom domains, with hostility and excitement responding fastest and negative and cognitive symptoms improving more slowly, guAug 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Acupoint Stimulation Provides Modest Postoperative Pain Relief After Cesarean Delivery: Systematic Review and Meta-Analysis
A systematic review and meta-analysis of 18 RCTs found that acupoint stimulation reduces postoperative pain scores after Cesarean delivery by small but statistically significant amounts across 48 hours, with moderate-to-high certainty evidence.
Aug 18, 2026
Meta-Analysis Shows Immediate Lymphatic Reconstruction Cuts Lymphedema Risk After Axillary DissectionA new meta-analysis of 30 studies indicates that immediate lymphatic reconstruction (ILR) during axillary lymph node dissection for breast cancer is associated with a 63% reduction in the risk of developing lymphedema, though study heterogeneity highlights the need for standardized diagnostic criteria.Jul 24, 2026
Pluralistic Model Proposed for Schizophrenia Spectrum: Beyond DopamineA new narrative review synthesizing evidence from 1980 to 2025 argues that schizophrenia spectrum disorders cannot be explained solely by dopaminergic dysfunction. The authors propose a pluralistic model involving multiple neurochemical and cellular processes, with implications for treatment development and biomarker-based stratification.Jul 24, 2026